Lupus Research Alliance News

BETHESDA, MD, April 16, 2024 — The Lupus Research Alliance (LRA), founder and administrator of the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), announced today at the Consortium’s first anniversary meeting an expanded partnership with the U.S. Food and Drug Administration (FDA) with the inclusion of the Center for Biologics Evaluation and Research (CBER). The addition […] READ MORE

April 11, 2024 The Lupus Research Alliance (LRA) and its clinical research affiliate Lupus Therapeutics (LT) are pleased to announce the group of industry partners working together on the implementation of the Lupus Nexus. The Lupus Nexus, one of LRA’s most ambitious and groundbreaking endeavors, is a first-of-its-kind lupus registry, biorepository, and data exchange platform […] READ MORE

April 2, 2024 Determined to alleviate healthcare disparities for minorities, J. Christopher Reed, JD, urges our lupus community to use the power of National Minority Health Month to spotlight the issue this April. First diagnosed at 16, Christopher fought debilitating lupus symptoms to graduate college in eight years and then Tulane University Law School in […] READ MORE

March 28, 2024 Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly successful Patient Advocates for Lupus Studies (PALS) program with the introduction of a first-in-lupus “Trial Buddy” component made possible by a partnership with Bristol Myers Squibb. The Trial Buddy addition provides extra support […] READ MORE

NEW YORK, NY, March 23, 2024 — The Lupus Research Alliance (LRA) mourns the loss of Richard K. DeScherer, the LRA’s Co-Founder and Co-Chair of the Board of Directors and Director Emeritus of Bloomberg L.P.  The LRA extends our deepest condolences to his wife Jennie DeScherer along with their children — Kate DeSantis, Christopher DeScherer […] READ MORE

March 24, 2024 Congress and passed and President Biden signed the 2024 spending bills, which include priorities that you, our advocates requested last March.  The Defense Appropriations bill includes $10 million for the Lupus Research Program within the Department of Defense.  And the Agriculture-FDA bill includes a provision expressing support for FDA’s engagement with industry […] READ MORE

March 20, 2024 Lupus is a complex autoimmune disease affecting millions worldwide with a staggering gender imbalance — about 9 of 10 people with lupus are women. Underlying biological, hormonal, or environmental factors likely contribute to why lupus affects females more often. Understanding why women are at greater risk for lupus could unlock novel treatments […] READ MORE

NEW YORK, N.Y. — March 14, 2024: Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on a Phase 1 trial of the company novel NK cell-based therapy AlloNK® (also known as AB-101), in combination with anti-CD20 antibodies, for patients with active lupus nephritis – inflammation […] READ MORE

March 4, 2024 Forget the old saying that March comes in like a lion and goes out like a lamb. At the Lupus Research Alliance, March is a time for intense, month-long action: when we salute Women’s History Month as well as advocate together on the Hill for lupus research funding.  Spotlighting a strong and […] READ MORE

NEW YORK, NY, February 28, 2024 — The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE). The LMTA provides investigators up […] READ MORE

February 1, 2024 In honor of Black History Month, we bring you the story of eloquent poet performer and lupus advocate Shanelle Gabriel.  With a focus on the theme “African Americans and the Arts,” Black History Month is a perfect time to hear from Shanelle, a woman who uses her poetry and music to elevate […] READ MORE

NEW YORK, NY, February 6, 2024 — Research Published in Nature Communications and Funded in Part by the Lupus Research Alliance Could Correct a Defect in Lupus Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious […] READ MORE